Biotech Trading Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.87 Cr
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -27.72%
- Profit Growth 472.82%
- Ebitda 441.63%
- Net Worth 0.29%
- Total Assets -0.90%
About Biotech Trading
Biotech Trading Private Limited (BTPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 July 2010 and has a history of 14 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aarti and Neetu Kharola serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110DL2010PTC205689
-
Company No.
205689
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jul 2010
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Biotech Trading Private Limited offer?
Biotech Trading Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Computer Hard Disk, RAM & Pen Drives, Compact Disc, Essential & Aromatic Oils, Natural Flower Oil, Nutraceuticals & Dietary Supplements, Dietary Supplements, Female Hygiene Products & Test Kits, Common Disease Medicines.
Who are the key members and board of directors at Biotech Trading?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aarti
|
Director | 02-Feb-2017 | Current |
|
Neetu Kharola
|
Director | 02-Feb-2017 | Current |
Financial Performance of Biotech Trading.
Biotech Trading Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 27.72% decrease. The company also saw a substantial improvement in profitability, with a 472.82% increase in profit. The company's net worth moved up by a moderate rise of 0.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Trading?
In 2020, Biotech Trading had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Blossomise Store LlpAarti and Neetu Kharola are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotech Trading?
Unlock and access historical data on people associated with Biotech Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
